Amarin Corp Plc (AMRN)

[couldbebetter]

I hope Dr. Bhatt sees that study. Would be ironic if it turns out that
Vascepa could help repair the damage this virus may cause or act as a
prophylactic against the inflammation the virus causes. This is why
Vascepa should be in the hands of BP...they could actually do the studies
required to answer some of these questions. Maybe the researchers from
Roche and Novartis (both based in Switzerland) will see this and figure
out it could give them a marketing edge if they acquire AMRN.